Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amanda R Patrick

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Drug Safety|March 13, 2015
Addressing limitations in observational studies of the association between glucose-lowering medications and all-cause mortality: a reviewElisabetta Patorno, Elizabeth M Garry, Amanda R Patrick, et al.
Pharmacoepidemiology and Drug Safety|March 26, 2013
Estimation using all available covariate information versus a fixed look-back window for dichotomous covariatesSteven M Brunelli, Joshua J Gagne, Krista F Huybrechts, et al.
Pediatrics|April 14, 2010
Comparative safety of antidepressant agents for children and adolescents regarding suicidal actsSebastian Schneeweiss, Amanda R Patrick, Daniel H Solomon, et al.
Circulation. Cardiovascular Quality and Outcomes|November 14, 2013
Cost-effectiveness of oral anticoagulants for treatment of atrial fibrillationWilliam J Canestaro, Amanda R Patrick, Jerry Avorn, et al.
Diabetologia|September 13, 2014
Observational studies of the association between glucose-lowering medications and cardiovascular outcomes: addressing methodological limitationsElisabetta Patorno, Amanda R Patrick, Elizabeth M Garry, et al.
Journal of General Internal Medicine|October 9, 2013
Trends in insulin initiation and treatment intensification among patients with type 2 diabetesAmanda R Patrick, Michael A Fischer, Niteesh K Choudhry, et al.
Drug Safety|February 11, 2014
Near-real-time monitoring of new drugs: an application comparing prasugrel versus clopidogrelJoshua J Gagne, Jeremy A Rassen, Niteesh K Choudhry, et al.
The American Journal of Medicine|March 14, 2007
Gaps in treatment among users of osteoporosis medications: the dynamics of noncomplianceM Alan Brookhart, Jerry Avorn, Jeffrey N Katz, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 15, 2011
The association between statin use and outcomes potentially attributable to an unhealthy lifestyle in older adultsAmanda R Patrick, William H Shrank, Robert J Glynn, et al.
BMJ Open|October 17, 2022
Using primary care data to assess comparative effectiveness and safety of apixaban and rivaroxaban in patients with nonvalvular atrial fibrillation in the UK: an observational cohort studyAshley Jaksa, Liza Gibbs, Seamus Kent, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Drug Safety|March 13, 2015
Addressing limitations in observational studies of the association between glucose-lowering medications and all-cause mortality: a reviewElisabetta Patorno, Elizabeth M Garry, Amanda R Patrick, et al.
Pharmacoepidemiology and Drug Safety|March 26, 2013
Estimation using all available covariate information versus a fixed look-back window for dichotomous covariatesSteven M Brunelli, Joshua J Gagne, Krista F Huybrechts, et al.
Pediatrics|April 14, 2010
Comparative safety of antidepressant agents for children and adolescents regarding suicidal actsSebastian Schneeweiss, Amanda R Patrick, Daniel H Solomon, et al.
Circulation. Cardiovascular Quality and Outcomes|November 14, 2013
Cost-effectiveness of oral anticoagulants for treatment of atrial fibrillationWilliam J Canestaro, Amanda R Patrick, Jerry Avorn, et al.
Diabetologia|September 13, 2014
Observational studies of the association between glucose-lowering medications and cardiovascular outcomes: addressing methodological limitationsElisabetta Patorno, Amanda R Patrick, Elizabeth M Garry, et al.
Journal of General Internal Medicine|October 9, 2013
Trends in insulin initiation and treatment intensification among patients with type 2 diabetesAmanda R Patrick, Michael A Fischer, Niteesh K Choudhry, et al.
Drug Safety|February 11, 2014
Near-real-time monitoring of new drugs: an application comparing prasugrel versus clopidogrelJoshua J Gagne, Jeremy A Rassen, Niteesh K Choudhry, et al.
The American Journal of Medicine|March 14, 2007
Gaps in treatment among users of osteoporosis medications: the dynamics of noncomplianceM Alan Brookhart, Jerry Avorn, Jeffrey N Katz, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 15, 2011
The association between statin use and outcomes potentially attributable to an unhealthy lifestyle in older adultsAmanda R Patrick, William H Shrank, Robert J Glynn, et al.
BMJ Open|October 17, 2022
Using primary care data to assess comparative effectiveness and safety of apixaban and rivaroxaban in patients with nonvalvular atrial fibrillation in the UK: an observational cohort studyAshley Jaksa, Liza Gibbs, Seamus Kent, et al.
Pageof 6